Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raviglione

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
IJTLD Open|November 15, 2024
Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?E Pontali, M Raviglione
The European Respiratory Journal|April 3, 2012
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistanceA Zumla, F Blasi, M Raviglione
Drugs|January 1, 1996
Epidemiology, control and treatment of multidrug-resistant tuberculosisP Chaulet, M Raviglione, F Bustreo
Lancet (London, England)|September 25, 2001
Private practitioners and public health: weak links in tuberculosis controlM Uplekar, V Pathania, M Raviglione
Lancet (London, England)|August 16, 2001
Direct observation for tuberculosis treatmentD Maher, M Raviglione, J W Lee
Lancet (London, England)|May 8, 1999
An African solution?D Maher, D Kibuga, M Raviglione, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 18, 2002
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998A Laszlo, M Rahman, M Espinal, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1997
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testingA Laszlo, M Rahman, M Raviglione, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 1999
Rational 'DOTS plus' for the control of MDR-TBM A Espinal, C Dye, M Raviglione, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2011
Tuberculosis and poverty: what is being doneJ Creswell, E Jaramillo, K Lönnroth, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
IJTLD Open|November 15, 2024
Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?E Pontali, M Raviglione
The European Respiratory Journal|April 3, 2012
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistanceA Zumla, F Blasi, M Raviglione
Drugs|January 1, 1996
Epidemiology, control and treatment of multidrug-resistant tuberculosisP Chaulet, M Raviglione, F Bustreo
Lancet (London, England)|September 25, 2001
Private practitioners and public health: weak links in tuberculosis controlM Uplekar, V Pathania, M Raviglione
Lancet (London, England)|August 16, 2001
Direct observation for tuberculosis treatmentD Maher, M Raviglione, J W Lee
Lancet (London, England)|May 8, 1999
An African solution?D Maher, D Kibuga, M Raviglione, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 18, 2002
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998A Laszlo, M Rahman, M Espinal, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1997
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testingA Laszlo, M Rahman, M Raviglione, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 1999
Rational 'DOTS plus' for the control of MDR-TBM A Espinal, C Dye, M Raviglione, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2011
Tuberculosis and poverty: what is being doneJ Creswell, E Jaramillo, K Lönnroth, et al.
Pageof 4